Sclerosis: Clinical Trials

2 trials for Sclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended, 1 withdrawn. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Suspended 1, Withdrawn 1

Follow Sclerosis: new trials by email Literature Review of Sclerosis trials Research Report on Sclerosis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of RD06-04 in Patients With Active Autoimmune Diseases
RD06-04 cell infusion - SLE, Sclerosis
Early Phase 1WithdrawnNanjing Bioheng Biotech Co., Ltd.2024-08-312026-02-03
Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis
MSC-Derived Exosomes, Placebo (Normal Saline) - Multiple Sclerosis
Early Phase 1SuspendedBiocells Medical202020-07-012025-08-28

Narrower conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Multiple Sclerosis (1)  ·  Neuromyelitis Optica (1)

Broader conditions

Autoimmune Diseases (2)  ·  Autoimmune Diseases of the Nervous System (2)  ·  Demyelinating Autoimmune Diseases, CNS (2)  ·  Demyelinating Diseases (2)  ·  Immune System Diseases (2)  ·  Nervous System Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Cardiovascular Diseases (1)  ·  Cranial Nerve Diseases (1)  ·  Eye Diseases (1)  ·  Myelitis, Transverse (1)  ·  Optic Nerve Diseases (1)  ·  Optic Neuritis (1)  ·  Skin Diseases (1)

Interventions

Saline Solution (1)

Sponsors

Biocells Medical (1)  ·  Nanjing Bioheng Biotech Co., Ltd. (1)

Countries

China (1)  ·  Poland (1)